Gregory Weinhoff

Biography

Gregory Weinhoff has more than twenty years of experience in healthcare finance and operations, including as a venture capital investor, operating executive, and board member with Audit Committee experience. Prior to joining Axovant, Dr. Weinhoff served as Partner at CHL Medical Partners focused on investments into start-up and early-stage companies across therapeutics, diagnostics, medical devices, and healthcare services. He was also the founding CEO of Amicus Therapeutics, and subsequently a member of the company board Audit Committee. Dr. Weinhoff was the founding President of VaxInnate and the President of Resolvyx, and he served in healthcare groups at J.H. Whitney & Co. and Morgan Stanley & Co. He received his M.D. from Harvard Medical School, his M.B.A. from Harvard Business School (Baker Scholar), and his A.B. in Economics magna cum laudefrom Harvard College Gregory Weinhoff has more than twenty years of experience in healthcare finance and operations, including as a venture capital investor, operating executive, and board member with Audit Committee experience. Prior to joining Axovant, Dr. Weinhoff served as Partner at CHL Medical Partners focused on investments into start-up and early-stage companies across therapeutics, diagnostics, medical devices, and healthcare services. He was also the founding CEO of Amicus Therapeutics, and subsequently a member of the company board Audit Committee. Dr. Weinhoff was the founding President of VaxInnate and the President of Resolvyx, and he served in healthcare groups at J.H. Whitney & Co. and Morgan Stanley & Co. He received his M.D. from Harvard Medical School, his M.B.A. from Harvard Business School (Baker Scholar), and his A.B. in Economics magna cum laudefrom Harvard College

Research Interest

Pharmaceutical Analysis and Quality Assurance  Industrial Pharmacy Clinical Pharmacy  Pharmaceutical Administration Medicinal Chemistry  Drug Discovery and Development